Nothing Special   »   [go: up one dir, main page]

Pant et al., 2002 - Google Patents

Noninvasive colorectal cancer screening

Pant et al., 2002

Document ID
8372144168069291680
Author
Pant K
McCracken J
Publication year
Publication venue
Digestive diseases and sciences

External Links

Snippet

Abnormal mucin with the STn epitope is produced by colorectal cancer cells and is immunologically distinguishable from normal colonic mucin. Herein we describe a technique of detecting abnormal mucin in fecal samples as a method of screening for colorectal …
Continue reading at link.springer.com (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/574Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57419Specifically defined cancers of colon
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes
    • C12Q1/6883Hybridisation probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • Y10S436/813Cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases

Similar Documents

Publication Publication Date Title
O’brien et al. Immunocytochemical Localization of Carcinoembryonic Antigen in Benign and Malignant Colorectal Tissues: Assessment of Diagnostic Value.
CN103476428B (en) For diagnosing blood markers thing and the monoclonal antibody thereof of epitheliogenic cancerg
KR920010296B1 (en) In Vitro Diagnosis of Gastrointestinal Cancer
JP2002525632A (en) YKL-40 as a marker and prognostic indicator for cancer
CN112345755A (en) Biomarker of breast cancer and application thereof
US5646002A (en) Method for increasing the sensitivity of assays for target ligand
CN101539574B (en) Application of Survivin antibody and esophageal cancer immunochromatography detecting test strip prepared therewith
WO1983004311A1 (en) Process for preparing fucose antigen and antibody for distinguishing it, measurement of tumor-associated sugar chain utilizing the same, and kit for the measurement
CN111879924A (en) Colloidal gold immunochromatography test paper for rapidly diagnosing hemoglobin and combining globin-hemoglobin compound and preparation method thereof
Tatsuta et al. Carcinoembryonic antigen in the bile in patients with pancreatic and biliary cancer correlation with cytology and percutaneous transhepatic cholangiography
US6531319B1 (en) Method of detecting colon cancer
Pant et al. Noninvasive colorectal cancer screening
US20200400673A1 (en) Methods for cancer detection by evaluation of glycan-binding patterns of immunoglobulins in gastrointestinal lavage fluid samples
CN109116023A (en) A kind of lung cancer marker anti-MM P12 autoantibody and its application
Muretto et al. An endogastric capsule for measuring tumor markers ingastric juice: An evaluation of the safety and efficacy of a new diagnostic tool
WO2002077649A1 (en) Method of diagnosing breast cancer
Frykholm et al. Expression of the carcinoma-associated antigens CA 19-9 and CA-50 in inflammatory bowel disease
Tobi et al. Increased expression of a putative adenoma-associated antigen in pre-colonoscopic effluent of patients with colorectal cancer
Vider et al. Carcinoembryonic antigen (CEA) monitoring in the management of radiotherapeutic patients
Pesce et al. Immune complexes in transitional cell carcinoma
Tsuji et al. Identification of an H antigen-like blood group antigen in sera of cancer patients using a novel monoclonal antibody raised against endometrial carcinoma
Tobi et al. Adenoma-derived antibody, Adnab-9 recognizes a membranebound glycoprotein in colonic tissue and effluent material from patients with colorectal neoplasia
US20050106642A1 (en) Saliva test for early diagnosis of cancers
Zamcheck et al. lignant Diseases of the Digestive Tract¹, 2, 3
CN113267626B (en) Test strip for early screening of cardia adenocarcinoma of high risk group